Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Harry Cheuk Hay Lau, Joseph Jao-Yiu Sung & Jun Yu. (2021) Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 13:1.
Read now
Read now
Filip Machaj, Jakub Rosik, Bartosz Szostak & Andrzej Pawlik. (2020) The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery. Expert Opinion on Drug Discovery 15:1, pages 85-99.
Read now
Read now
Shushan Ge, Haiqing Zhong, Xuewei Ma, Yingbo Zheng, Yi Zou, Fang Wang, Yan Wang, Yue Hu, Yuezhen Li, Wen Liu, Wenjie Guo, Qiang Xu & Yisheng Lai. (2020) Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1240-1257.
Read now
Read now
Angus G Dalgleish. (2019) Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?. Expert Review of Anticancer Therapy 19:12, pages 1001-1003.
Read now
Read now
Articles from other publishers (16)
Hsin-Pei Weng, Chiao-Hsu Ke, Chun-Wei Tung, Akiyoshi Tani, Chia-Chi Wang, Wen-Yuan Yang, Yu-Shan Wang, Winston Han, Chi-Hsun Liao, Hirotaka Tomiyasu & Chen-Si Lin. (2023) Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles. Cancer Cell International 23:1.
Crossref
Crossref
Shufeng Ji, Hao Yu, Dan Zhou, Xulong Fan, Yan Duan, Yijiang Tan, Min Lang & Guoli Shao. (2023) Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer. Journal of Translational Medicine 21:1.
Crossref
Crossref
Marawan Ahmed, Aravindhan Ganesan & Khaled Barakat. (2022) Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1. BMC Chemistry 16:1.
Crossref
Crossref
Ahmed F. Abdel-Magid. (2022) Inhibitors of Transforming Growth Factor Beta Receptor 1 (TGFβr1) May Enhance the Efficacy of Several Monoclonal Antibodies as Cancer Therapy. ACS Medicinal Chemistry Letters 13:9, pages 1405-1407.
Crossref
Crossref
Liliana-Roxana Balahura, Andreea-Daniela Lazar, Sorina Dinescu & Marieta Costache. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
28
.
Young Hun Chung, Jooneon Park, Hui Cai & Nicole F. Steinmetz. (2021) S100A9‐Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma. Advanced Science 8:21, pages 2101796.
Crossref
Crossref
Jakub Rosik, Bartosz Szostak, Filip Machaj & Andrzej Pawlik. (2021) The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences 22:6, pages 3081.
Crossref
Crossref
Krzysztof Kotowski, Jakub Rosik, Filip Machaj, Stanisław Supplitt, Daniel Wiczew, Karolina Jabłońska, Emilia Wiechec, Saeid Ghavami & Piotr Dzięgiel. (2021) Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets. Cancers 13:4, pages 909.
Crossref
Crossref
Antonio B. Ward, Adam B. Keeton, Xi Chen, Tyler E. Mattox, Alex B. Coley, Yulia Y. Maxuitenko, Donald J. Buchsbaum, Troy D. Randall, Gang Zhou & Gary A. Piazza. (2020) Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS. MedComm 1:2, pages 121-128.
Crossref
Crossref
Chufan Zhang, Jianing Chen, Qian Song, Xiaoyan Sun, Meijuan Xue, Zuyi Yang & Jun Shang. (2020) Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types. International Immunopharmacology 85, pages 106633.
Crossref
Crossref
Laura C. Cappelli, Mekha A. Thomas, Clifton O. BinghamIIIIII, Ami A. Shah & Erika Darrah. (2020) Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis. Immunological Reviews 294:1, pages 106-123.
Crossref
Crossref
Hongjun Zhang, Kun Liu, Qinglin Pu, Abdelghani Achab, Michael J. Ardolino, Mangeng Cheng, Yongqi Deng, Amy C. Doty, Heidi Ferguson, Xavier Fradera, Ian Knemeyer, Ravi Kurukulasuriya, Yu-hong Lam, Charles A. Lesburg, Theodore A. Martinot, Meredeth A. McGowan, J. Richard Miller, Karin Otte, Purakattle J. Biju, Nunzio Sciammetta, Nicolas Solban, Wensheng Yu, Hua Zhou, Xiao Wang, David Jonathan Bennett & Yongxin Han. (2019) Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. ACS Medicinal Chemistry Letters 10:11, pages 1530-1536.
Crossref
Crossref
Young-IL Jeong, So Young Yoo, Jeong Heo & Dae Hwan Kang. (2019) Chlorin e6-Conjugated and PEGylated Immune Checkpoint Inhibitor Nanocomposites for Pulmonary Metastatic Colorectal Cancer. ACS Omega 4:20, pages 18593-18599.
Crossref
Crossref
Sudhir Agrawal & Ekambar R. Kandimalla. (2019) Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors. Immuno-Oncology Technology 3, pages 15-23.
Crossref
Crossref
T. Crosson, K. Roversi, M. Balood, R. Othman, M. Ahmadi, J.‐C. Wang, P. J. Seadi Pereira, M. Tabatabaei, R. Couture, T. Eichwald, A. Latini, R.D. Prediger, M. Rangachari, C. R. Seehus, S. L. Foster & S. Talbot. (2019) Profiling of how nociceptor neurons detect danger – new and old foes. Journal of Internal Medicine 286:3, pages 268-289.
Crossref
Crossref
Keriann M. Backus, Jian Cao & Sean M. Maddox. (2019) Opportunities and challenges for the development of covalent chemical immunomodulators. Bioorganic & Medicinal Chemistry 27:15, pages 3421-3439.
Crossref
Crossref